Literature DB >> 16094319

Increased infarct size and lack of hyperphagic response after focal cerebral ischemia in peroxisome proliferator-activated receptor beta-deficient mice.

Denis Arsenijevic1, Fabienne de Bilbao, Julie Plamondon, Eric Paradis, Philippe Vallet, Denis Richard, Wolfgang Langhans, Panteleimon Giannakopoulos.   

Abstract

Peroxisome proliferator-activated receptors (PPARs) are involved in energy expenditure, regulation of inflammatory processes, and cellular protection in peripheral tissues. Among the different types of PPARs, PPARbeta is the only one to be widely expressed in cortical neurons. Using PPARbeta knockout (KO) mice, we report here a detailed investigation of the role of PPARbeta in cerebral ischemic damage, associated inflammatory and antioxidant processes as well as food intake regulation after middle cerebral artery occlusion (MCAO). The PPARbeta KO mice had a two-fold increase in infarct size compared with wild-type (WT) mice. Brain oxidative stress was dramatically enhanced in these KO mice, as documented by an increased content of malondialdehyde, decreased levels of glutathione and manganese superoxide dismutase, and no induction of uncoupling protein 2 (UCP2) mRNA. Unlike WT mice, PPARbeta KO mice showed a marked increase of prooxidant interferon-gamma but no induction of nerve growth factor and tumor necrosis factor alpha after MCAO. In WT mice, MCAO resulted in inflammation-specific transient hyperphagia from day 3 to day 5 after ischemia, which was associated with an increase in neuropeptide Y (NPY) mRNA. This hyperphagic phase and NPY mRNA induction were not observed in PPARbeta KO mice. Furthermore, our study also suggests for the first time that UCP2 is involved in MCAO food intake response. These data indicate that PPARbeta plays an important role in integrating and regulating central inflammation, antioxidant mechanisms, and food intake after MCAO, and suggest that the use of PPARbeta agonists may be of interest for the prevention of central ischemic damage.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16094319     DOI: 10.1038/sj.jcbfm.9600200

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  32 in total

1.  Peroxisome proliferator-activated receptor delta regulation of miR-15a in ischemia-induced cerebral vascular endothelial injury.

Authors:  Ke-Jie Yin; Zhen Deng; Milton Hamblin; Yi Xiang; Huarong Huang; Jifeng Zhang; Xiaodan Jiang; Yanzhuang Wang; Y Eugene Chen
Journal:  J Neurosci       Date:  2010-05-05       Impact factor: 6.167

Review 2.  Activation of PPARδ: from computer modelling to biological effects.

Authors:  Shirin Kahremany; Ariela Livne; Arie Gruzman; Hanoch Senderowitz; Shlomo Sasson
Journal:  Br J Pharmacol       Date:  2014-12-15       Impact factor: 8.739

3.  Vascular PPARδ protects against stroke-induced brain injury.

Authors:  Ke-Jie Yin; Zhen Deng; Milton Hamblin; Jifeng Zhang; Y Eugene Chen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-01-04       Impact factor: 8.311

4.  Oral administration of a novel lipophilic PPARδ agonist is not neuroprotective after rodent cerebral ischemia.

Authors:  Samuel Knauss; Matthias Endres; Florian Blaschke; Claudia Hindinger; Alexander Kunz
Journal:  J Cereb Blood Flow Metab       Date:  2017-11-21       Impact factor: 6.200

Review 5.  Assessing post-stroke behavior in mouse models of focal ischemia.

Authors:  Mustafa Balkaya; Jan M Kröber; Andre Rex; Matthias Endres
Journal:  J Cereb Blood Flow Metab       Date:  2012-12-12       Impact factor: 6.200

6.  Characterization of long-term gait deficits in mouse dMCAO, using the CatWalk system.

Authors:  E Caballero-Garrido; J C Pena-Philippides; Z Galochkina; E Erhardt; T Roitbak
Journal:  Behav Brain Res       Date:  2017-05-23       Impact factor: 3.332

7.  Ligand activation of peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) attenuates carbon tetrachloride hepatotoxicity by downregulating proinflammatory gene expression.

Authors:  Weiwei Shan; Prajakta S Palkar; Iain A Murray; Emily I McDevitt; Mary J Kennett; Boo Hyon Kang; Harriet C Isom; Gary H Perdew; Frank J Gonzalez; Jeffrey M Peters
Journal:  Toxicol Sci       Date:  2008-07-12       Impact factor: 4.849

8.  Effects of gemfibrozil on outcome after permanent middle cerebral artery occlusion in mice.

Authors:  Qingmin Guo; Guangming Wang; Xiaowei Liu; Shobu Namura
Journal:  Brain Res       Date:  2009-05-07       Impact factor: 3.252

Review 9.  Role of peroxisome-proliferator-activated receptor beta/delta (PPARbeta/delta) in gastrointestinal tract function and disease.

Authors:  Jeffrey M Peters; Holly E Hollingshead; Frank J Gonzalez
Journal:  Clin Sci (Lond)       Date:  2008-08       Impact factor: 6.124

Review 10.  Nuclear receptors in neurodegenerative diseases.

Authors:  Rebecca Skerrett; Tarja Malm; Gary Landreth
Journal:  Neurobiol Dis       Date:  2014-05-27       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.